Oscar Health (NYSE:OSCR) Insider Sells $325,822.00 in Stock

by · The Cerbat Gem

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) insider Janet Liang sold 10,360 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $325,822.00. Following the transaction, the insider owned 248,697 shares of the company’s stock, valued at approximately $7,821,520.65. This represents a 4.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Up 2.4%

Shares of OSCR opened at $32.53 on Friday. The company’s 50-day moving average price is $30.58 and its 200 day moving average price is $23.27. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.55. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The firm has a market cap of $10.04 billion, a P/E ratio of 23.24, a price-to-earnings-growth ratio of 0.65 and a beta of 2.37.

Oscar Health (NYSE:OSCR – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same quarter last year, the firm posted ($0.89) earnings per share. Oscar Health’s revenue was up 70.4% compared to the same quarter last year. On average, sell-side analysts forecast that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on OSCR shares. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a report on Friday, August 7th. UBS Group lifted their price objective on Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Barclays boosted their price objective on Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. The Goldman Sachs Group reissued a “neutral” rating and set a $30.00 target price on shares of Oscar Health in a research note on Tuesday, August 11th. Finally, Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $26.22.

Get Our Latest Stock Report on Oscar Health

Institutional Investors Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently made changes to their positions in OSCR. California State Teachers Retirement System grew its position in Oscar Health by 3,214.2% in the 2nd quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock valued at $222,543,000 after buying an additional 7,567,600 shares during the last quarter. BIT Capital GmbH raised its position in Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after buying an additional 5,227,152 shares during the last quarter. Morgan Stanley raised its position in Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after buying an additional 2,043,758 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after acquiring an additional 1,922,732 shares during the period. Finally, Thrive Capital Management LLC lifted its stake in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

(Get Free Report)

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.

See Also